Related Experiment Video

Updated: Sep 28, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Regulation of Bcl-2 during androgen-unresponsive progression of prostate cancer

C A Rothermund1, D Kondrikov, M-F Lin

  • 1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198-4525, USA.

Prostate Cancer and Prostatic Diseases
|December 24, 2002
PubMed

Insights

Prostate cancer becomes resistant to treatment as it progresses. This study found that androgen-unresponsive prostate cancer cells lose Bcl-2 protein, impacting apoptosis regulation and treatment resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • Prostate cancer progression to an androgen-unresponsive state is a major treatment challenge.
  • Androgen-unresponsive prostate cancer exhibits resistance to conventional therapies like chemotherapy and radiation.
  • Understanding apoptosis regulation is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate the role of Bcl-2 family proteins in the transition of prostate cancer from androgen-responsive to androgen-unresponsive states.
  • To identify molecular mechanisms underlying apoptosis resistance in advanced prostate cancer.

Main Methods:

  • Utilized LNCaP prostate cancer cell line at various passages as an in vitro model for disease progression.
  • Analyzed mRNA expression of Bcl-2 family genes under normal growth conditions.
  • Performed Western blot analysis to assess Bcl-2 and Bax protein levels.
  • Evaluated apoptosis induction in response to oxidative stress, paclitaxel, and sodium butyrate.

Main Results:

  • Bcl-2 family gene mRNA levels were similar in both responsive and unresponsive cells.
  • Bcl-2 protein was present in androgen-responsive cells but absent in androgen-unresponsive cells.
  • Bax protein levels were comparable between responsive and unresponsive cells.
  • Androgen-unresponsive cells showed resistance to oxidative stress-induced apoptosis but responded to paclitaxel or sodium butyrate.

Conclusions:

  • The loss of Bcl-2 protein in androgen-unresponsive prostate cancer cells is associated with altered apoptosis regulation.
  • Despite resistance to some stimuli, the apoptotic machinery remains functional in androgen-unresponsive cells.
  • Targeting apoptosis pathways may offer therapeutic potential for advanced prostate cancer.

More Related Videos

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture10:38

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

Published on: November 22, 2019

Murine Prostate Micro-dissection and Surgical Castration08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...